Health policy experts are pushing for changes to the federal government’s system of funding the research and development of new pharmaceuticals in the hopes of making drugs that are necessary to patients’ health more affordable.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?